Table 1.

Comorbidities of COVID-19 patients

	Epidemiology (death%) (n = 72,314)	Severe/non-severe Pneumonia (n = 38/72)	Severe/non-severe (n = 173/926)	ICU/non-ICU (n = 13/28)	ARDS/non-ARDS (n = 53/56)	Non-survivor/survivor (n = 54/137)	Non-survivor/survivor (n = 32/20)	Non-survivor (n = 82)
Hypertension	12.8/6	39.47/29.17c	23.7/13.4	15/14	39.6/28.6	48/23%c		56.1
Diabetes	5.3/7.3	21.05/9.72	16.2/5.7	8/25	20.8/1.8b	31/14b	22/10	18.3
Coronary heart diseases	4.2/10.5		5.8/1.8	23/11	5.7/7.1	24/1d	9/10	20.7
Cerebrovascular diseases		7.89/5.56	2.3/1.2		11.3/0b		22/0	12.2
COPD	2.4/6.3	10.53/2.78a	3.5/0.6	8/0	3.8/3.6	7/1a	6/10	14.6
Kidney diseases			1.7/0.5		15.1/3.6a	4/0a		4.9
Liver diseases			0.6/2.4	0/1		—		2.4
Cancer	0.5/5.6		1.7/0.8	0/1		0/1	3/5	7.3
Secondary infection			0.6/2.4					6.1
Immunodeficiency			0/0.2					17.1
Others						20/8a		3.7 (surgery)
Total	26/−		38.7/21	38/29		67/40c		76.8
Reference no.	80	85	24	31	45	101	95	97

ARDS, acute respiratory distress syndrome; COPD, chronic obstructive pulmonary disease; ICU, intensive care unit.

^aP < 0.05,

^bP < 0.01,

^cP < 0.001,

^dP < 0.0001.